Working through the National Institutes of Health, the White House has licensed research tools and intellectual property for COVID-19 technologies to the UN-backed program Medicines Patent Pool. The technologies will allow manufacturers from low and middle income countries to make COVID-19 vaccines and ramp up testing.
Eleven U.S. technologies including diagnostic tech, research tools and early stage COVID-19 vaccine candidates were included in the list of licensed technologies.
“I welcome the generous contribution NIH has made to C-TAP and its example of solidarity and sharing,” said Tedros Adhanom Ghebreyesus, PhD, director-general of WHO.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
